title: Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide.
abstract: The structurally divergent agents gallamine and hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide (W84) are known to interact competitively at a common allosteric site on muscarinic receptors. Previous studies reported that the M2 selectivity of gallamine depended largely on the EDGE (172-175) sequence in the second outer loop (o2) and on 419Asn near the junction of o3 and the seventh transmembrane domain (TM7), whereas the selectivity of W84 depended on nearby residues 177Tyr and 423Thr. However, it has so far proven difficult to confer the high sensitivity for allosteric modulation of the M2 subtype onto the weakly sensitive M5 subtype by substituting these key residues. We now have found that M2 423Thr, not 419Asn, is the dominant residue in the o3/TM7 region for gallamine's high potency, although 419Asn can substitute for 423Thr in some contexts; in contrast, the presence of 419Asn reduces the potency of W84 in every context we have studied. In addition, the orientation of 177Tyr is crucial to high sensitivity toward W84, and it seems that the proline residue at position 179 in M5 (corresponding to M2 172Glu) may interfere with that orientation. Consistent with these observations, a mutant M5 receptor with these three key mutations, M5P179E, Q184Y, and H478T, showed dramatically increased sensitivity for W84 (>100-fold), compared with the wild-type M5 receptor. This same mutant receptor approached M2 sensitivity toward gallamine. Thus, gallamine and W84 derive high potency from the same receptor domains (epitopes in o2 and near the junction between o3 and TM7), even though these allosteric agents have quite different structures.
authors.affiliation: Department of Psychiatry, H073, Hershey Medical Center, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
authors.forename: Xi-Ping
authors.initials: XP
authors.lastname: Huang
authors.forename: Stefanie
authors.initials: S
authors.lastname: Prilla
authors.forename: Klaus
authors.initials: K
authors.lastname: Mohr
authors.forename: John
authors.initials: J
authors.lastname: Ellis
mesh_terms: D000495:Allosteric Site; D000595:Amino Acid Sequence; D005703:Gallamine Triethiodide / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D054833:Isoindoles; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010797:Phthalimides / Q000737:chemistry / Q000494:pharmacology*; D011487:Protein Conformation; D043585:Receptor, Muscarinic M2 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D013912:Threonine / Q000378:metabolism*; D014443:Tyrosine / Q000378:metabolism*
chemical_list: D054833:Isoindoles; D010797:Phthalimides; D043585:Receptor, Muscarinic M2; C013017:hexamethylenebis(dimethyl-(3-phthalimidopropyl)ammonium bromide); D013912:Threonine; D014443:Tyrosine; D005703:Gallamine Triethiodide